4//SEC Filing
Mack Randall 4
Accession 0001192482-18-000050
CIK 0001588972other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:05 PM ET
Size
8.3 KB
Accession
0001192482-18-000050
Insider Transaction Report
Form 4
Mack Randall
Senior VP, Development
Transactions
- Exercise/Conversion
Common Stock
2018-01-18+3,100→ 34,713 total - Tax Payment
Common Stock
2018-01-18$8.89/sh−961$8,543→ 33,752 total - Exercise/Conversion
Restricted Stock Units
2018-01-18−3,100→ 9,300 total→ Common Stock (3,100 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 18, 2017, the reporting person was granted 12,400 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001602336
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 5:05 PM ET
- Size
- 8.3 KB